Trial Profile
An Open-Label Trial to Explore Symptomatic Therapy for Application Site Reaction to SPM962 in Healthy Subject
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 May 2014
Price :
$35
*
At a glance
- Drugs Rotigotine (Primary) ; Dexamethasone; Diphenhydramine
- Indications Fibromyalgia; Parkinson's disease; Restless legs syndrome
- Focus Adverse reactions; Therapeutic Use
- Sponsors Otsuka Pharmaceutical
- 02 May 2014 New trial record